# K072092: Xpod/Xmap Nerve Stimulator

- Pathway: 510(k) (Traditional)
- Applicant: Xavant Technology (Pty), Ltd.
- Decided: Nov 15, 2007 after 108 days
- Product code: BXN (Stimulator, Nerve, Battery-Powered)
- Device class: 2
- Regulation: 21 CFR 868.2775
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K882438 (1988). 7 ancestors in all.
12 later devices descend from it; 2 cite it directly.
0 of 20 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K023342: Neuro-Trace Iii Kit, Neuro-Trace Iii Regional Block Cable, Neuro-Trace Iii Nerve Mapping Probe, Neuro-Trace Iii Nerve BG, Hdc Corp. (2004) Summary page 2.
- K052313: Stimuplex HNS-12, Model 4892098, Stockert GmbH (2005) Summary page 2.

## Most influential descendants
- K093591: Stimpod Model NMS-400 Nerve Stimulator (2009), 10 descendants of its own
- K102084: Stimpod NMS450 Nerve Stimulator (2010), 6 descendants of its own
- K173526: SENTIO MMG Gen 2 (2018), 2 descendants of its own
- K161091: STIMPOD NMS460 Nerve Stimulator (2017), 2 descendants of its own
- K243636: Neuralytix iD3 System (NTX-9001) (2025), 1 descendant of its own

## Indications for use
The XPOD/XMAP is a nerve stimulation device Intended to be used by an anesthetist during regional anesthesia procedures wherever peripheral anesthesia is normally applied. The XMAP is intended for percutaneous nerve mapping using the non-invasive Nerve Mapping Probe (supplied). The XPOD is intended for nerve localization using invasive electrodes/needles (not supplied).

Source page: https://510kreport.com/device/K072092
Methodology: https://510kreport.com/methodology